Article
Development of a molecular barcode detection system for pancreaticobiliary malignancies and comparison with next-generation sequencing.
Cancer genetics - 1 Jan 2024
Ohyama Hiroshi, Hirotsu Yosuke, Amemiya Kenji, Mikata Rintaro, Amano Hiroyuki, Hirose Sumio, Oyama Toshio, Iimuro Yuji, Kojima Yuichiro, Mochizuki Hitoshi, Kato Naoya, Omata Masao
Abstract excerpt
BACKGROUND: Obtaining sufficient tumor tissue for genomic profiling is challenging in pancreaticobiliary cancer (PBCA). We determined the utility of molecular barcoding (MB) of liquid biopsies (bile, duodenal fluid, and plasma) for highly sensitive genomic diagnosis and detection of druggable mutations for PBCA. METHODS: Two in-house panels of 60 genes (non-MB panel) and 21 genes using MB (MB panel) were used for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
